ID

16696

Descrição

Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc (OSI Pharmaceuticals) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of Study: Adverse Events

Link

https://clinicaltrials.gov/ct2/show/NCT00373425

Palavras-chave

Versões (1)
  1. 01/08/2016 01/08/2016 -
Transferido a

1 de agosto de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Adverse Events, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425

Inglês

Adverse Events, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 Formulários  
Adverse Events
Descrição

Adverse Events

Did any Adverse Events occur?
Descrição

Adverse Events

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0877248
Long-Term Follow-Up Adverse Events
Descrição

Long-Term Follow-Up Adverse Events

Sign/Symptom or Adverse Event
Descrição

Record ALL Baseline Signs and Symptoms that occur within 24 hours prior to First Dosing. ALL Adverse Events, including Serious Adverse Events should be recorded. In addition, ALL Serious Adverse Events must be recorded on the Serious Adverse Event Report Form.

Tipo de dados

text

Alias
UMLS CUI [1]
C0877248
Severity (CTC Grade)
Descrição

Grade severity (1,2,3,4,5) using NCI Common Terminology Criteria for Adverse Events (CTCAE) Version 3.0. A change in CTC grade should be recorded as a separate event.

Tipo de dados

integer

Alias
UMLS CUI [1]
C1710066
Start Date: pretreatment
Descrição

Adverse Event Start Date

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2697888
Start Date
Descrição

If not pretreatment, please specify start date

Tipo de dados

date

Alias
UMLS CUI [1]
C2697888
Stop Date: continuing
Descrição

Adverse Event End Date

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2697886
Stop Date
Descrição

If not continuing, please specify stop date

Tipo de dados

date

Alias
UMLS CUI [1]
C2697886
Serious
Descrição

If event is serious, complete the SERIOUS ADVERSE EVENT FORM and fax to the appropriate number on the CRF General lnstructions page.

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1710056
Related to study treatment
Descrição

A change in relationship should be recorded as a separate event.

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1510821
Action taken
Descrição

If event caused drug discontinuation, complete the Withdrawal From Study Due To Nonserious Adverse Event Form and fax to the appropriate number on the CRF General lnstructions page.

Tipo de dados

integer

Alias
UMLS CUI [1]
C2826626
Voltar ao início da página

Similar models

Adverse Events, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Adverse Events
Adverse Events
Item
Did any Adverse Events occur?
boolean
C0877248 (UMLS CUI [1])
Item Group
Long-Term Follow-Up Adverse Events
Adverse Events
Item
Sign/Symptom or Adverse Event
text
C0877248 (UMLS CUI [1])
Item
Severity (CTC Grade)
integer
C1710066 (UMLS CUI [1])
Adverse Event Severity
Code List
Severity (CTC Grade)
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
Adverse Event Start Date
Item
Start Date: pretreatment
boolean
C2697888 (UMLS CUI [1])
Adverse Event Start Date
Item
Start Date
date
C2697888 (UMLS CUI [1])
Adverse Event End Date
Item
Stop Date: continuing
boolean
C2697886 (UMLS CUI [1])
Adverse Event End Date
Item
Stop Date
date
C2697886 (UMLS CUI [1])
Seriousness of Adverse Event
Item
Serious
boolean
C1710056 (UMLS CUI [1])
Relation to study treatment
Item
Related to study treatment
boolean
C1510821 (UMLS CUI [1])
Item
Action taken
integer
C2826626 (UMLS CUI [1])
Action Taken
Code List
Action taken
CL Item
None (1)
CL Item
Dose Reduced (2)
CL Item
Dose Temporarily Withheld (3)
CL Item
Dose Temporarily Withheld and Reduced (4)
CL Item
Drug Discontinued (5)
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial